Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Rizatriptan Rizatriptan benzoate 7.265mg equivalent to rizatriptan 5mg Orodispersible tablet Apotex NZ Limited Apotex Research Private Limited, Bangalore, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Apo-Rizatriptan Rizatriptan benzoate 14.53mg equivalent to rizatriptan 10mg Orodispersible tablet Apotex NZ Limited Apotex Research Private Limited, Bangalore, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Microshield 2 Chlorhexidine Skin Cleanser Chlorhexidine gluconate 2%w/v Topical solution Schulke New Zealand Limited Ensign Laboratories Pty Limited, Melbourne, Australia
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Moxifloxacin-Claris Moxifloxacin hydrochloride 1.74mg/mL equivalent to moxifloxacin 1.60mg/mL Solution for infusion Baxter Healthcare Limited Claris Injectables Limited, Ahmedabad, India
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Mylanta Antacid Double Strength Aluminium hydroxide 80mg/mL Magnesium hydroxide 80mg/mL Simethicone 6mg/mL as 20mg/mL of simeticone emulsion Q7-2587 30% Oral suspension Johnson & Johnson (New Zealand) Limited Ensign Laboratories Pty Limited, Melbourne, Australia
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Mylanta Antacid Original Aluminium hydroxide 40mg/mL Magnesium hydroxide 40mg/mL Simethicone 4mg/mL as 17.3mg/mL of simethicone emulsion Q7-2587 30% Oral suspension Johnson & Johnson (New Zealand) Limited Ensign Laboratories Pty Limited, Melbourne, Australia
|
Dated this 31st day of July 2018.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).